Providence Capital Advisors’s Omnicell OMCL Stock Holding History

Providence Capital Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	-$2K	–	407
2022 Q1	$2K	Buy	+12	New	+$1.73K	﹤0.01%	381

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Providence Capital Advisors's OMCL Position: Q2 2022 in Review

Providence Capital Advisors sold out of Omnicell (OMCL) in Q2 2022, closing a stake of 12 shares — an estimated $2K sold.

Providence Capital Advisors first reported a position in OMCL in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 385 funds tracked by Wall St. Rank hold OMCL as of Q2 2022.

Providence Capital Advisors reported no remaining Omnicell position as of Q2 2022 after selling out during the quarter.
Providence Capital Advisors sold 12 Omnicell shares in Q2 2022, an estimated $2K.
Providence Capital Advisors first reported a position in Omnicell in Q1 2022 and held it in 1 quarter.
Providence Capital Advisors's Omnicell position peaked at $2K in Q1 2022.
385 funds tracked by Wall St. Rank held Omnicell as of Q2 2022.

Based on Providence Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.